Synergistic Attenuation of Chronic Pain Using Mu Opioid and Cannabinoid Receptor 2 Agonists

Neuropharmacology - United Kingdom
doi 10.1016/j.neuropharm.2016.12.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Modulation of Mu-Opioid Receptor Signaling by Cannabinoid CB1 Receptor Through Heteromerization, a Novel Analgesic Target

Biophysical Journal
Biophysics
2019English

14β-O-Cinnamoylnaltrexone and Related Dihydrocodeinones Are Mu Opioid Receptor Partial Agonists With Predominant Antagonist Activity

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2009English

Selective Up-Regulation of Functional Mu-Opioid Receptor Splice Variants by Chronic Opioids

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2016English

Ligands for the Sigma Receptor and the Mu-Opioid Receptor

English

Effects of Mu, Kappa, and Delta Opioid Receptor Agonists on the Function of Hypothalamic–pituitary–adrenal Axis in Monkeys

Psychoneuroendocrinology
Mental HealthEndocrineEndocrinologyAutonomic SystemsPsychiatryBiological PsychiatryMetabolismDiabetes
2008English

Novel Fentanyl-Based Dual Μ/Δ-Opioid Agonists for the Treatment of Acute and Chronic Pain

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2013English

Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors

English

Single-Channel Observations on the Mu-Opioid Receptor

Biophysical Journal
Biophysics
1986English

Cannabinoid Agonists and Antagonists Discriminated by Receptor Binding in Rat Cerebellum

British Journal of Pharmacology
Pharmacology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy